E-cigarettes and the marketing push that surprised everyone. by McKee, Martin
McKee, M (2013) E-cigarettes and the marketing push that surprised
everyone. BMJ (Clinical research ed), 347. f5780. ISSN 0959-8138
DOI: 10.1136/bmj.f5780
Downloaded from: http://researchonline.lshtm.ac.uk/1236252/
DOI: 10.1136/bmj.f5780
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial
http://creativecommons.org/licenses/by-nc/2.5/
OBSERVATIONS
E-cigarettes and the marketing push that surprised
everyone
Ongoing debate in Europe over regulation may favour the interests of the industry
Martin McKee professor of European public health
London School of Hygiene and Tropical Medicine
Many important conversations at the European Regional
Committee of the World Health Organization take place in the
corridors. This year, at its meeting in Izmir, Turkey, a common
topic was the dramatic rise in the marketing of e-cigarettes now
being seen in many countries. Where they are allowed,
advertisements seem to be appearing everywhere. New outlets
are also appearing, in some cases beside schools, as in Slovenia.
Governments that had imposed restrictions have been coming
under pressure to relax them from manufacturers and, in some
cases, from groups portraying e-cigarettes as an effective means
of harm reduction.
Many in Izmir wondered whether this intense activity was
confined to their own country, but it was soon clear that this
was something affecting all of Europe. But why now? The
e-cigarette, a battery powered device designed tomimic smoking
and to deliver a dose of nicotine without many nasty cancer
producing substances in conventional cigarettes, has been around
for a long time. The first patent was in 1963, and China has
been exported e-cigarettes since 2005. Nobody had seen the big
marketing push coming. What has changed?
As we discussed the various experiences the answer emerged.
When e-cigarettes first became available the big tobacco
companies ignored them, as they thought they would never
replace the real thing. After all, manufacturers had worked for
many years to get the ingredients of their cigarettes just right.
Not the tobacco, of course: it was all the other things they put
in, such as ammonia, to ensure that the nicotine would be
absorbed faster. This was so that children and teenagers starting
smoking would be hooked by the nicotine kick before they were
put off by the coughing and to reduce the risk of adults
overcoming their addiction. Or menthol and other flavourings,
again designed to appeal to youngsters. The products were
perfectly designed to achieve what the manufacturers wanted:
more young people smoking and fewer adults giving up.
But several things have changed. Firstly, countries introduced
bans, of varying strength, on cigarette advertising. Of course,
the companies managed to get round many of the bans, through
positive portrayal of smoking in movies or on social media. Or
by brand stretching: launching other products, such as clothing
ranges, with the same name that could be advertised legally. Or
by clever use of imaging—you don’t need to write Marlboro
on the distinctive red and white images for teenagers to know
what they mean. But with every new generation the companies
needed to reconnect their marketing with the act of smoking.
E-cigarettes look like the real thing and offer the perfect
opportunity.
Secondly, many countries banned smoking in public places.
Smokers have used this as a stimulus to quit. After all, who
wants to go out in cold or wet weather every time you want a
nicotine fix? Once again, e-cigarettes came to the rescue,
offering the possibility for people to get their fixes and remain
addicted while staying warm and dry.
But the final factor was that smoking was becoming socially
unacceptable in many countries. Many of those present in Izmir
described how the tide had turned in their countries, with
smoking regarded as an addiction and with those who smoked
given sympathy and support. Certainly smokers were no longer
looked up to. Tobacco control advocates can take much of the
credit, pointing out that the Marlboro man didn’t ride off into
the sunset but died a lingering death from cancer. Even those
celebrities who did smoke were embarrassed to be seen doing
it in public. This change in attitude is what the tobacco
companies feared most. So what they needed was for the people
who are role models to young people to do something that may
not exactly be smoking but that looks very much like it. There
is even a helpful website showing who these celebrities are.1
Unsurprisingly, e-cigarette use has risen rapidly among US
teenagers in the past year, many of whom are also smoking the
real thing.2 3
But can’t e-cigarettes help people to quit? This is the line that
the tobacco companies are pushing in some countries, although
they are careful not to make health claims where this would
mean that their products would be regulated as medicines, as
they are in Denmark, Lithuania, and Slovenia. In fact, the vast
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majority of people who quit smoking do so without help. A
recent, widely quoted study showed that smoking e-cigarettes
could help some people quit but that it was no more effective
than other means of nicotine replacement.4
Manywell respected public health professionals have advocated
e-cigarettes as a form of harm reduction, as they are obviously
much safer than smoking real cigarettes. But this may bemissing
the point. There are many other ways for people who cannot
shake of their addiction to get their nicotine fix, none of which
have the enormous downside of glamorising smoking again.
The debate is now moving to the European level and is intense
in the European parliament, to the delight of the tobacco
industry, as it threatens to delay the long awaited Tobacco
Products Directive, justifying the vast lobbying resources the
industry has deployed in Brussels.5 The parliament is divided
between those party groupings supporting the European
Commission’s recommendation that e-cigarettes be regulated
as a medicine and those who support their much less rigorous
regulation as consumer products. However, the conversations
in Izmir suggested a growing consensus among national
governments in favour of going down the medicines route, as
will happen in the United Kingdom, even while the groupings
of MEPs that include the UK’s Conservatives and Liberal
Democrats favour the consumer products route in Brussels.
Some governments have also taken advantage of wording in
existing tobacco advertising bans that includes objects that look
like cigarettes, as in Finland, Lithuania, and Slovenia. What is
clear is that the more attention policy makers give to the
aggressive marketing of e-cigarettes in their own countries, the
more they conclude that the downsides far exceed any benefits.
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